
|Articles|November 13, 2015
Approvals of New Lung Cancer, Melanoma Drugs Highlight Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/approvals-of-new-lung-cancer-melanoma-drugs-highli" target="_blank">View the story "Approvals of New Lung Cancer, Melanoma Drugs Highlight Specialty Pharmacy Week in Review" on Storify</a>]
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
2
New CKD Outcome Set Tells Pharmacists What to Measure
3
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
4
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
5


































































































